---
schema_version: "secwatch.filing_event.v1"
accession: "0001411690-24-000066"
form_type: "8-K"
ticker: "BNGO"
cik: "0001411690"
company_name: "Bionano Genomics, Inc."
filed_at: "2024-12-02T23:59:59+00:00"
generated_at: "2026-05-29T11:08:53.949293+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Bionano Genomics stockholders approve issuance of up to 35M shares upon warrant exercise

## Summary
- Vote passed: 22.9M for, 6.2M against, 1.4M abstentions, no broker non-votes.
- Approval covers Series A and B warrants from July 4, 2024 private placement to institutional investors.
- Issuance required for Nasdaq Listing Rule 5635(d) compliance; warrants were already outstanding.
- Potential dilutive impact: up to 35M shares vs. ~86M outstanding as of August 12, 2024 record date.

## SEC filing metadata
- accession: 0001411690-24-000066
- form_type: 8-K
- ticker: BNGO
- cik: 0001411690
- company_name: Bionano Genomics, Inc.
- filed_at: 2024-12-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1411690/000141169024000066/0001411690-24-000066-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1411690/000141169024000066/bngo-20241127.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001411690-24-000066
- JSON: https://secwatch.observer/filing/0001411690-24-000066.json
- Plain text: https://secwatch.observer/filing/0001411690-24-000066.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.